Company Filing History:
1 out of 3 
1 out of 5,069 
1 out of 832,680 Years Active: 2001-2005
Title: The Innovative Contributions of Michel Kaczorek in Monoclonal Antibody Development
Introduction: Michel Kaczorek, an accomplished inventor based in Montferrier, France, has made significant strides in the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of two patents to his name, Kaczorek's pioneering work is shaping the landscape of immunoglobulin production.
Latest Patents: Kaczorek's latest innovations include a patent for a recombinant baculovirus, which is utilized in the production of monoclonal antibodies. This invention introduces a novel expression vector that efficiently produces immunoglobulins within insect cells. The technology features two distinct expression cassettes, with the first coding for a portion of an immunoglobulin heavy chain and controlled by a specific baculovirus promoter. Similarly, the second cassette encodes for a portion of the immunoglobulin light chain under another baculovirus promoter. Both promoters operate at separate loci, enhancing the overall efficiency of antibody production.
Additionally, Kaczorek has developed the monoclonal recombinant anti-rhesus D (D7C2) antibody. This patent focuses on the cloning of DNA fragments responsible for the light and heavy chain variable domains of the D7C2 monoclonal antibody using baculovirus. The resulting engineered DNA fragments are expressed within insect host cells, allowing for the production of the anti-rhesus D monoclonal antibody and expanding its potential applications.
Career Highlights: Throughout his career, Michel Kaczorek has been associated with reputable institutions, including the Institut National De La Recherche Agronomique, where he has contributed to cutting-edge research and innovation in biotechnology.
Collaborations: Kaczorek's journey in the field has been enriched by collaborations with talented individuals such as Hassan Chaabihi and Léna Edelman, who have worked alongside him in advancing research initiatives.
Conclusion: Michel Kaczorek's innovative contributions, particularly in the realm of monoclonal antibodies, underscore his role as a key inventor in biotechnology. His patented technologies hold promise for future advancements in therapeutic applications, showcasing the potential impact of his work on the medical and research communities.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.